Rhythm Pharmaceuticals Inc (RYTM)
59.96
+0.93
(+1.58%)
USD |
NASDAQ |
Nov 22, 12:27
Rhythm Pharmaceuticals Total Liabilities (Quarterly): 352.36M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 352.36M |
June 30, 2024 | 202.35M |
March 31, 2024 | 197.07M |
December 31, 2023 | 162.99M |
September 30, 2023 | 156.72M |
June 30, 2023 | 127.66M |
March 31, 2023 | 125.92M |
December 31, 2022 | 118.22M |
September 30, 2022 | 108.42M |
June 30, 2022 | 82.05M |
March 31, 2022 | 49.06M |
December 31, 2021 | 45.37M |
September 30, 2021 | 33.56M |
June 30, 2021 | 36.70M |
March 31, 2021 | 41.26M |
December 31, 2020 | 20.54M |
Date | Value |
---|---|
September 30, 2020 | 18.54M |
June 30, 2020 | 17.73M |
March 31, 2020 | 20.66M |
December 31, 2019 | 27.50M |
September 30, 2019 | 28.42M |
June 30, 2019 | 29.42M |
March 31, 2019 | 16.01M |
December 31, 2018 | 13.95M |
September 30, 2018 | 8.091M |
June 30, 2018 | 7.432M |
March 31, 2018 | 5.785M |
December 31, 2017 | 6.948M |
September 30, 2017 | 86.66M |
June 30, 2017 | 5.113M |
December 31, 2016 | 45.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.73M
Minimum
Jun 2020
352.36M
Maximum
Sep 2024
97.23M
Average
65.55M
Median
Total Liabilities (Quarterly) Benchmarks
Eli Lilly and Co | 61.29B |
TG Therapeutics Inc | 393.86M |
Regeneron Pharmaceuticals Inc | 8.116B |
Voyager Therapeutics Inc | 95.73M |
Krystal Biotech Inc | 96.47M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 363.57M |
Shareholders Equity (Quarterly) | 11.22M |
Current Ratio | 3.487 |